Effectiveness and Tolerability of Vildagliptin plus Metformin Dual Therapy Compared with Insulin Secretagogue plus Metformin Dual Therapy in Patients with Type 2 Diabetes—A Real-World Study (China PDS)

LIXIAN CHEN; YING HAN; DAQING HU; HUI JIN; NAILONG YANG; XIAOYUN SHI; QUANMIN LI; LINLANG LIANG; LI ZANG; MINGMING LIU; JAMES HE; YIMING MU

doi:10.2337/db18-2267-pub

Effectiveness and Tolerability of Vildagliptin plus Metformin Dual Therapy Compared with Insulin Secretagogue plus Metformin Dual Therapy in Patients with Type 2 Diabetes—A Real-World Study (China PDS)

Diabetes ◽

10.2337/db18-2267-pub ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 2267-PUB

Author(s):

LIXIAN CHEN ◽

YING HAN ◽

DAQING HU ◽

HUI JIN ◽

NAILONG YANG ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Dual Therapy ◽

Insulin Secretagogue

Download Full-text

Treatment Maintenance Duration of Dual Therapy with Metformin and Sitagliptin in Type 2 Diabetes – Real-World Data From Odyssee Study

Value in Health ◽

10.1016/j.jval.2014.08.640 ◽

2014 ◽

Vol 17 (7) ◽

pp. A334-A335 ◽

Cited By ~ 2

Author(s):

S. Leproust ◽

J. Dallongeville ◽

P. Valensi ◽

E. Boutmy ◽

C. Moisan ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Dual Therapy ◽

Real World Data ◽

World Data

Download Full-text

Abstract #802036: Safety and Efficacy of Faster Acting Insulin Aspart in People With Type 2 Diabetes and Chronic Kidney Disease: A Real-World Study from India

Endocrine Practice ◽

10.1016/s1530-891x(20)39507-0 ◽

2020 ◽

Vol 26 ◽

pp. 101-102

Author(s):

Supratik Bhattacharyya

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Real World ◽

Insulin Aspart ◽

Safety And Efficacy ◽

Acting Insulin

Download Full-text

Abstract #288 Efficacy of Canagliflozin 300 Mg in Overweight and Obese Type 2 Diabetes Mellitus Patients in a Real World Setting

Endocrine Practice ◽

10.1016/s1530-891x(20)47133-2 ◽

2018 ◽

Vol 24 ◽

pp. 76-77

Author(s):

Pankaj Aneja ◽

Kunal Aneja ◽

Gaurav Bhalla ◽

Navneet Wadhwa

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Real World ◽

Real World Setting

Download Full-text

Abstract #1151: Lower Risk of Hypoglycemia and Less Health Care Utilization in Basal Insulintreated Patients with Type 2 Diabetes (T2D) After Switching to Insulin Glargine 300 UNITS/ML (GLA-300) VS Other Basal Insulins in Real-World Clinical Settings

Endocrine Practice ◽

10.1016/s1530-891x(20)44281-8 ◽

2017 ◽

Vol 23 ◽

pp. 317-318

Author(s):

Fang Liz Zhou ◽

Fen Ye ◽

Vineet Gupta ◽

Rishab Gupta ◽

Jennifer Sung ◽

...

Keyword(s):

Type 2 Diabetes ◽

Health Care ◽

Health Care Utilization ◽

Insulin Glargine ◽

Real World ◽

Lower Risk ◽

Care Utilization ◽

Clinical Settings

Download Full-text

Effectiveness of FreeStyle Libre Flash Glucose Monitoring System Observed in Real-World, Chart Review Study in Adults with Type 2 Diabetes

10.1055/s-0039-1688212 ◽

2019 ◽

Cited By ~ 1

Author(s):

J Kröger ◽

U Aigner ◽

S Maxeiner ◽

B Paschen ◽

L Rose ◽

...

Keyword(s):

Type 2 Diabetes ◽

Monitoring System ◽

Real World ◽

Chart Review ◽

Glucose Monitoring ◽

Flash Glucose Monitoring ◽

Freestyle Libre ◽

Review Study ◽

Flash Glucose Monitoring System

Download Full-text

Real world data of Type 2 Diabetes Mellitus (T2DM) obese patients using another GLP1 receptor agonist (GLP1–RA) and switching to Semaglutide in Spain

Endocrine Abstracts ◽

10.1530/endoabs.70.ep197 ◽

2020 ◽

Author(s):

Jersy Cardenas ◽

Gomez Nancy Sanchez ◽

Sierra Poyatos Roberto Miguel ◽

Luca Bogdana Luiza ◽

Mostoles Naiara Modroño ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Real World ◽

Receptor Agonist ◽

Obese Patients ◽

Real World Data ◽

World Data

Download Full-text

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses

Diabetes ◽

10.2337/db18-1057-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1057-P

Author(s):

SEAN D. SULLIVAN ◽

TIMOTHY S. BAILEY ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Insulin Detemir ◽

Insulin Degludec ◽

Subgroup Analyses

Download Full-text

Type 2 Diabetes Mellitus and Renal Impairment in Real-World with Large Outpatient Electronic Medical Records—Antihyperglycemic Medication Dose Adjustment

Diabetes ◽

10.2337/db18-1553-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1553-P

Author(s):

SANG MO HONG ◽

CHEOL-YOUNG PARK

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Renal Impairment ◽

Electronic Medical Records ◽

Real World ◽

Medical Records ◽

Dose Adjustment ◽

Medication Dose

Download Full-text

Evaluation of Treatment Persistence in Individuals with Type 2 Diabetes in a Real-World Setting

Diabetes ◽

10.2337/db18-135-or ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 135-OR

Author(s):

WILLIAM T. CEFALU ◽

TAMARA DARSOW ◽

MATT PETERSEN ◽

LIISA PALMER ◽

ELLEN THIEL ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Treatment Persistence ◽

Real World Setting

Download Full-text

Triple vs. Dual Therapy with Low-Dose Dapagliflozin plus Saxagliptin vs. Each Monocomponent Added to Metformin in Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db18-1149-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1149-P

Author(s):

JULIO ROSENSTOCK ◽

SHIRA PERL ◽

EVA K. JOHNSSON ◽

STEPHAN JACOB

Keyword(s):

Type 2 Diabetes ◽

Low Dose ◽

Dual Therapy

Download Full-text